Vavers E, Zvejniece L, Maurice T, Dambrova M
Front Pharmacol. 2019; 10:223.
PMID: 30941035
PMC: 6433746.
DOI: 10.3389/fphar.2019.00223.
Wood J, LaPalombara Z, Ahmari S
Philos Trans R Soc Lond B Biol Sci. 2018; 373(1742).
PMID: 29352023
PMC: 5790822.
DOI: 10.1098/rstb.2017.0023.
Avila-Luna A, Galvez-Rosas A, Durand-Rivera A, Ramos-Languren L, Rios C, Arias-Montano J
Metab Brain Dis. 2017; 33(1):99-105.
PMID: 29052075
DOI: 10.1007/s11011-017-0126-x.
Gozzi A, Crestan V, Turrini G, Clemens M, Bifone A
Psychopharmacology (Berl). 2010; 209(1):37-50.
PMID: 20111859
DOI: 10.1007/s00213-009-1772-4.
Quintero G, Spano D, Lahoste G, Harrison L
Neuroreport. 2008; 19(16):1563-6.
PMID: 18845937
PMC: 2649821.
DOI: 10.1097/WNR.0b013e3283118434.
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.
Fleming S, Salcedo J, Hutson C, Rockenstein E, Masliah E, Levine M
Neuroscience. 2006; 142(4):1245-53.
PMID: 16934409
PMC: 3108485.
DOI: 10.1016/j.neuroscience.2006.07.005.
Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats.
Diaz Heijtz R, Castellanos F
Behav Brain Funct. 2006; 2:18.
PMID: 16729883
PMC: 1524794.
DOI: 10.1186/1744-9081-2-18.
Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.
Waddington J, OTuathaigh C, OSullivan G, Tomiyama K, Koshikawa N, Croke D
Psychopharmacology (Berl). 2005; 181(4):611-38.
PMID: 16041535
DOI: 10.1007/s00213-005-0058-8.
Wasp uses venom cocktail to manipulate the behavior of its cockroach prey.
Libersat F
J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2003; 189(7):497-508.
PMID: 12898169
DOI: 10.1007/s00359-003-0432-0.
Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.
De Souza I, Dawson N, Clifford J, Waddington J, Meredith G
Psychopharmacology (Berl). 2003; 169(1):28-34.
PMID: 12830366
DOI: 10.1007/s00213-003-1466-2.
Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Deveney A, Waddington J
Psychopharmacology (Berl). 1996; 124(1-2):40-9.
PMID: 8935799
DOI: 10.1007/BF02245604.
Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.
Marin C, Engber T, Chaudhuri P, Peppe A, Chase T
Psychopharmacology (Berl). 1996; 123(2):215-21.
PMID: 8741947
DOI: 10.1007/BF02246181.
Neurobehavioral development of CD-1 mice after combined gestational and postnatal exposure to ozone.
DellOmo G, Fiore M, Petruzzi S, Alleva E, Bignami G
Arch Toxicol. 1995; 69(9):608-16.
PMID: 8660138
DOI: 10.1007/s002040050221.
Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney A, Waddington J
Br J Pharmacol. 1995; 116(3):2120-6.
PMID: 8640354
PMC: 1908936.
DOI: 10.1111/j.1476-5381.1995.tb16420.x.
Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.
McDougall S, Crawford C, Nonneman A
Psychopharmacology (Berl). 1993; 111(2):225-32.
PMID: 7870957
DOI: 10.1007/BF02245528.
Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice.
Tirelli E, Terry P
Psychopharmacology (Berl). 1993; 110(1-2):69-75.
PMID: 7870901
DOI: 10.1007/BF02246952.
Observational studies of dopamine D1 and D2 agonists in squirrel monkeys.
Rosenzweig-Lipson S, Hesterberg P, Bergman J
Psychopharmacology (Berl). 1994; 116(1):9-18.
PMID: 7862937
DOI: 10.1007/BF02244865.
Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
Daly S, Waddington J
Psychopharmacology (Berl). 1993; 113(1):45-50.
PMID: 7862827
DOI: 10.1007/BF02244332.
Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
Katz J, Witkin J
Psychopharmacology (Berl). 1993; 113(1):19-25.
PMID: 7862823
DOI: 10.1007/BF02244328.
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.
Gnanalingham K, Erol D, Hunter A, Smith L, Jenner P, Marsden C
Psychopharmacology (Berl). 1995; 117(3):275-86.
PMID: 7770603
DOI: 10.1007/BF02246102.